BioElectronics Expands Distribution to the Balkans
FREDERICK, Md., Oct. 4, 2012 /PRNewswire/ -- BioElectronics Corporation (BIEL), maker of consumer medical electronics, announced today that it has agreed to distribution terms with ZEPHYRUS d.o.o. to distribute its ActiPatch® Musculoskeletal Pain Relief, Allay™ Menstrual Pain Relief and RecoveryRx™ Postoperative and Wound Care Therapy brands in the Balkan region. The countries involved include Albania, Bosnia and Herzegnovina, Croatia, Kosovo, Macedonia, Montenegro, Serbia, and Slovenia. The combined populations of these nations exceeds 25 million.
"This is a growing part of the world that is beginning to prosper. We are pleased to add experienced, successful distributors in our effort to bring our pain relief products to markets worldwide," said Ben Fichter, Marketing Manager.
"We believe the populations of these countries will embrace a safe, drug free, inexpensive product that provides more effective pain relief than any drug therapy. Our unique devices, patterned after larger devices that have been used safely and effectively for years in hospitals and physical therapy clinics, are five times better and 100 percent safer than over the counter drugs," Mr. Fichter said.
"ZEPHYRUS d.o.o. specializes in medical device sales and has a longstanding, deep relationship with its customers. We are very proud of the quality of our service and excited about the opportunity to bring BIEL's excellent products to a new marketplace," said Jovan Radakovic, Director.
About BioElectronics Corporation
BioElectronics is an award winning developer and manufacturer of advanced medical devices. Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal ailments, the Allay™ Menstrual Cycle Pain Therapy, and RecoveryRx™ for surgical procedures and wound care. The unique therapy delivery system, using patented technology, provides a cost-effective home care to reduce soft tissue pain and accelerate healing. For more information, please visit www.bielcorp.com.
SOURCE BioElectronics Corporation